生命科学资讯

UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge

Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals

Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study

Chutes & Ladders—Moderna CMO steps down in leadership mix-up

Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk

Medtronic hit with $382M antitrust ruling over surgical device monopoly

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

NICE greenlights Abbott's cardiac sensor implant for NHS

Astellas tops expectations as Vyloy sales surge outshines trial setback

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA

Flagship-founded antibody biotech Generate is latest to mull IPO

A cut above: Veradermics locks in $256M IPO and shares spike

Angitia raises $130M to challenge Amgen with bone-building bispecifics

GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop

Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024

Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate

FDA’s rare pediatric disease voucher program revived by 2026 government funding bill

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates

Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout

GSK's new CEO looking for $2B to $4B deals 'hiding in plain sight'